|
PPAPDC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.89189999619555E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33439999997032E-06 |
| Normal-vs-Stage2 |
6.539500E-03 |
| Normal-vs-Stage3 |
5.09950000004977E-08 |
| Normal-vs-Stage4 |
2.60390042861047E-10 |
| Stage1-vs-Stage2 |
4.662600E-01 |
| Stage1-vs-Stage3 |
5.105700E-02 |
| Stage1-vs-Stage4 |
1.032040E-04 |
| Stage2-vs-Stage3 |
5.590400E-02 |
| Stage2-vs-Stage4 |
2.257500E-03 |
| Stage3-vs-Stage4 |
7.183500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60929999992732E-07 |
| Normal-vs-AfricanAmerican |
9.388600E-04 |
| Normal-vs-Asian |
4.96940000260793E-08 |
| Caucasian-vs-AfricanAmerican |
7.301400E-01 |
| Caucasian-vs-Asian |
1.018230E-01 |
| AfricanAmerican-vs-Asian |
6.418400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22269999961E-07 |
| Normal-vs-Female |
2.4518999997003E-07 |
| Male-vs-Female |
3.257200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70359999998693E-06 |
| Normal-vs-Age(41-60Yrs) |
1.24179999949625E-07 |
| Normal-vs-Age(61-80Yrs) |
2.10359999999188E-05 |
| Normal-vs-Age(81-100Yrs) |
2.338100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.101600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.045000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.130000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.440000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.734400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.130600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.296500E-02 |
| Classical-VS-Follicular |
9.697600E-01 |
| Classical-VS-Other |
1.222760E-01 |
| Classical-VS-Normal |
4.57730000014145E-07 |
| Tall-VS-Follicular |
1.550210E-01 |
| Tall-VS-Other |
2.952600E-01 |
| Tall-VS-Normal |
7.18719999959205E-07 |
| Follicular-VS-Other |
2.087000E-01 |
| Follicular-VS-Normal |
3.360800E-04 |
| Other-VS-Normal |
1.558200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70295999999404E-05 |
| Normal-vs-N1 |
1.04649955368075E-10 |
| N0-vs-N1 |
5.597600E-04 |
|
|
